Objective:

To map the available evidence on reported changes in HCV care during the COVID-19 pandemic across the HCV cascade of care.

Approach:

Key Findings:

• COVID-19-related health service disruptions negatively impacted HCV management.
• A modeling study indicated potential excess cases of hepatocellular carcinoma and liver disease deaths due to delays in HCV care.
• The HCV cascade of care framework is useful for monitoring the impact of COVID-19 on HCV management.

Interpretation:

Limitations:

• Excluded studies focusing solely on COVID-19 mitigation strategies without pre-pandemic data.
• Did not standardize comparator periods across studies, which may affect the comparability of findings.

Conclusion:

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.